BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Renowned Dermatologist Dr. Neil Sadick Joins Histogen, Inc. Scientific Advisory Board


7/22/2010 12:07:47 PM

SAN DIEGO, July 22, 2010 – Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn cells grown under embryonic conditions, today announced that Dr. Neil Sadick has joined the Company’s Scientific Advisory Board.

A prominent dermatologist and researcher, Dr. Sadick holds positions as Clinical Professor of Dermatology at Weill Cornell Medical College and President of the Cosmetic Surgery Foundation, in addition to being the founder of Sadick Dermatology, a leading aesthetic medicine practice in New York. He is board certified in Dermatology, Cosmetic Surgery, Internal Medicine, and Hair Transplantation.

"We are excited to welcome Dr. Sadick to Histogen’s Scientific Advisory Board,” said Dr. Gail Naughton, CEO and Chairman of the Board for Histogen. “His clinical and research background and expertise will be invaluable as development and clinical studies of Histogen’s dermal filler and hair regrowth applications progress.”

Dr. Sadick is the recipient of the Jobst Award for Research in Vascular Diseases, American Cancer Society Research Award, American Medical Association’s Continuing Medical Education Award, and is a lead research physician for Merck Pharmaceutical, ESC Medical, Jobst Biersdorf, and Aesclepion. He has authored more than 500 peer-reviewed articles, written/edited more than 10 books on cosmetic surgery, hair and vein treatment, and contributed more than 75 medical book chapters.

“Histogen’s technology, and its numerous applications in aesthetic medicine, are truly unique and exciting,” said Dr. Sadick. “As a member of the Company’s SAB, I look forward to contributing to the development of Histogen’s near-term applications, particularly in the areas of cosmetic surgery and hair restoration where these next-generation products can have a large impact.”

About Histogen

Histogen, launched in 2007, seeks to redefine regenerative medicine by developing a series of high value products that do not contain embryonic stem cells or animal components. Through Histogen's proprietary bioreactors that mimic the embryonic environment, newborn cells are encouraged to naturally produce the vital proteins and growth factors from which the Company has developed its rich product portfolio. Histogen has two product families – a proprietary liquid complex of embryonic-like proteins and growth factors, and a human Extracellular Matrix (ECM) material, ExCeltrix. For more information, please visit http://www.histogen.com.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES